Sterol .DELTA.14 reductase screen
AssigneeAmerican Cyanamid Company
InventorsMargaret H. K. Lai, Donald R. Kirsch, Martin Bard
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmerican Cyanamid Company
InventorsMargaret H. K. Lai, Donald R. Kirsch, Martin Bard
Estimating the term…
A binary assay identifies agents that inhibit sterol .DELTA.14 reductase involved in ergosterol biosynthesis. In the primary screen, sterol .DELTA.14 reductase inhibition by a test sample is assayed by adding the test sample to a culture of Neurospora crassa having an erg-3 mutation and also to a culture of a strain having an erg-1 mutation, comparing the extent of growth inhibition after incubation in the two cultures, and identifying as positives those samples that show growth inhibition in the erg-3 culture exceeding that in the erg-1 culture. In the secondary screen, samples that test positive in the primary screen are reassayed by adding the test sample to a culture of a Saccharomyces cerevisiae strain into which has been introduced multiple copies of a gene encoding sterol .DELTA.14 reductase and also to a strain of S. cerevisiae that does not have the introduced gene; positive samples are identified after incubation by observation that growth inhibition in the culture having no introduced reductase gene exceeds growth inhibition in the culture having the introduced reductase gene. In preferred embodiments, a known inhibitor of sterol .DELTA.14 reductase is employed in solidified media in both the primary and the secondary screens, resulting in an assay that is highly sensitive and specific for the detection of sterol .DELTA.14 reductase inhibitors.
A method for screening for the presence or absence of sterol .DELTA.14 reductase inhibition by a test sample, said method comprising:
A method for screening for the presence or absence of sterol .DELTA.14 reductase inhibition by a test sample, said method comprising:
A method for screening for the presence or absence of sterol .DELTA.14 reductase inhibition by a test sample, which comprises:
A plasmid containing, as an insert, the nucleotide sequence of SEQ ID NO. 1.
Dependencies are inferred from the claim text.